Grindeks to take part in development of Mildronate analogue
17 March 2010
Maria Bailey
Please Login to read the full article.
17 March 2010
Maria Bailey
maria.bailey@informa.com
Grindeks has signed an agreement for the development of a structural analogue of its leading product, the cardiovascular Mildronate (meldonium), with the Latvian institute of organic synthesis (OSI) where the original product was discovered. The parties want to find other partners for the project.
Professor...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zafgen to take severe obesity candidate into Phase II with $33M in new funds
- Ukraine's pharma market grows 16% in 2010, with value outstripping volume
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
